Thymosin Alpha 1(10xVials)

CA$320.00

Thymosin Alpha 1 (Tα1) is a peptide known for its potent immunomodulatory properties. Here are the primary uses and benefits:

Uses and Benefits

  1. Immune System Enhancement:

    • T Cell Activation: Tα1 enhances the maturation and activity of T cells, which are crucial for adaptive immunity. It also activates natural killer cells and other immune system components, improving the body's ability to fight infections​ (Muscle and Brawn)​​ (Wikipedia)​.
    • Treatment of Viral Infections: It has been used to treat chronic viral infections like Hepatitis B and C, improving the immune response and aiding in viral clearance​ (Wikipedia)​.
  2. Anti-Inflammatory Effects:

    • Inflammation Reduction: Tα1 helps reduce chronic and acute inflammation by downregulating pro-inflammatory cytokines such as IL-1β and TNF-α. This makes it beneficial for conditions involving excessive inflammation​ (Muscle and Brawn)​.
  3. Cancer Therapy Support:

    • Cancer Treatment: Tα1 has shown promise in enhancing the immune response in cancer patients, helping to slow down tumor growth and improve the effectiveness of other cancer therapies​ (WJGNet)​.
  4. Adjuvant in Vaccination:

    • Vaccine Response Enhancement: Tα1 can improve the immunogenicity of vaccines, making them more effective. It has been particularly noted to enhance the response to influenza vaccines​ (WJGNet)​.
  5. Chronic Disease Management:

    • Autoimmune Diseases: Tα1 has been investigated for its potential to modulate the immune response in autoimmune diseases such as rheumatoid arthritis and psoriatic arthritis, helping to reduce symptoms and manage the disease​ (Muscle and Brawn)​​ (Wikipedia)​.

Administration and Dosage

  • Forms: Thymosin Alpha 1 is typically administered via subcutaneous injection. Nasal sprays are also available for those who prefer not to use injections​ (Muscle and Brawn)​.
  • Dosage: The dosage varies depending on the condition being treated. For chronic hepatitis B, the recommended dosage is 1.6 mg twice weekly for 6-12 months. For cancer therapy, dosages can range from 1.6 mg administered on varying schedules over several months​ (WJGNet)​.